Xradia Announces $1.4M NIH Grant for Nano-scale X-ray Microscope
Concord, CA – September 29, 2005: Xradia, Inc., a developer and manufacturer of ultra-high-resolution X-ray imaging systems for 3D tomography and nanotechnology applications, today announced receipt of a $1.4 million grant from the National Institutes of Health (NIH) for the development of an ultra-high resolution X-ray microscope for the three-dimensional imaging of complex biological systems.
Nanotechnology is emerging as a critical field essential to enabling fundamental breakthroughs having tremendous potential for affecting biomedicine. In this respect, single-cell tomography using X-rays, has been identified as a major technology need by NIH. “With unique capabilities in developing high-resolution X-ray nano-tomography systems, Xradia is in an ideal position to meet this emerging need,” said Dr. Michael Feser, Engineering Vice President at Xradia.
The company will expand its product line by introducing a new X-ray tomography system designed specifically for biomedical applications. This new product will include capabilities of automated 3D tomographic imaging with single cell or tissue sections at 30nm resolution, and high throughput. A cryogenic sample stage will preserve samples in a frozen-hydrated state, and enable simple preparation without the need for sectioning. “The new X-ray microscope developed with these funds will bridge the gap between visible light and electron microscopy, and will provide biologists with a powerful and unique vision tool offering new insights on the structure and behavior of cellular organelles.” Said Dr. Wenbing Yun, company founder and President. Development of the new microscope is expected to be complete in less than twelve months.
About Xradia, Inc.
Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include metrology in semiconductor IC production, scientific equipment, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to demand for its unique X-ray imaging products.
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.
About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press
Dr. Jochen Tham
Phone +49 3641 64-3949
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772